Other OTC - Delayed Quote • USD
China Medicine Corporation (CHME)
As of February 15 at 9:30 AM EST. Market Open.
Breakdown
TTM
Total Revenue
65,755.0180
Cost of Revenue
43,753.6280
Gross Profit
22,001.3900
Operating Expense
10,296.0990
Operating Income
11,705.2910
Other Income Expense
-2,221.4650
Pretax Income
9,483.8260
Tax Provision
3,761.6800
Net Income Common Stockholders
-113.3230
Diluted NI Available to Com Stockholders
-113.3230
Basic EPS
-0.04
Diluted EPS
-0.05
Basic Average Shares
31,675.8220
Diluted Average Shares
31,675.8220
Total Operating Income as Reported
11,705.2910
Total Expenses
54,049.7270
Net Income from Continuing & Discontinued Operation
6,030.6770
Normalized Income
7,371.0165
EBIT
11,705.2910
EBITDA
13,406.4400
Reconciled Cost of Revenue
43,753.6280
Reconciled Depreciation
1,701.1490
Net Income from Continuing Operation Net Minority Interest
6,030.6770
Total Unusual Items Excluding Goodwill
-2,221.4650
Total Unusual Items
-2,221.4650
Normalized EBITDA
15,627.9050
Tax Rate for Calcs
0.0004
Tax Effect of Unusual Items
-881.1255
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade